• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide.

作者信息

Heinemann D F

机构信息

Division of General Medicine, State University of New York at Stony Brook, USA.

出版信息

Geriatrics. 2000 May;55(5):31-6; quiz 39.

PMID:10826263
Abstract

During the past decade, numerous organizations and associations have published recommendations for the prevention and treatment of osteoporosis. For the primary care physician, the most applicable of these--due to its reliance on clinical trial data and its scope--is the clinical guide published by the National Osteoporosis Foundation. The guide addresses risk assessment, bone mineral density testing, diagnosis, nutritional supplementation, and pharmacologic therapy, including consideration of the newer agents used to slow or manage osteoporosis progression. Reflecting one of the key deficiencies in the clinical trial data, the guide applies predominantly to a patient population of postmenopausal white females. The refined design of new osteoporosis studies will in time allow for recommendations that apply to a more diverse patient population.

摘要

相似文献

1
Osteoporosis. An overview of the National Osteoporosis Foundation clinical practice guide.
Geriatrics. 2000 May;55(5):31-6; quiz 39.
2
Defining strategies for improving the identification and management of osteoporosis in the primary care setting.确定在初级保健环境中改善骨质疏松症识别与管理的策略。
Int J Fertil Womens Med. 2003 Nov-Dec;48(6):261-72.
3
The role of the primary care physician in diagnosis and management of osteoporosis.初级保健医生在骨质疏松症诊断与管理中的作用。
Int J Fertil Womens Med. 2002 May-Jun;47(3):116-22.
4
Osteoporosis in older men and women.老年男性和女性的骨质疏松症。
Conn Med. 2003 Sep;67(8):481-6.
5
[Grave deficiencies in the diagnosis and therapy of osteoporosis. Expensive fracture landing].
MMW Fortschr Med. 2002 Feb 14;144(7):20-1.
6
Postmenopausal osteoporosis treatment guidelines.绝经后骨质疏松症治疗指南。
Aust Fam Physician. 2000 Aug;29(8):751-3, 756-8.
7
Health-economic comparison of three recommended drugs for the treatment of osteoporosis.三种推荐用于治疗骨质疏松症的药物的卫生经济学比较
Int J Clin Pharmacol Res. 2004;24(1):1-10.
8
Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.绝经后骨质疏松症女性3年内骨折、心血管事件和乳腺癌发生率的比较。
J Am Geriatr Soc. 2004 Sep;52(9):1543-8. doi: 10.1111/j.1532-5415.2004.52420.x.
9
Implications of expanding disease definitions: the case of osteoporosis.疾病定义扩展的影响:以骨质疏松症为例。
Health Aff (Millwood). 2007 Nov-Dec;26(6):1702-11. doi: 10.1377/hlthaff.26.6.1702.
10
Bone mineral density thresholds for pharmacological intervention to prevent fractures.预防骨折的药物干预的骨密度阈值。
Arch Intern Med. 2004 May 24;164(10):1108-12. doi: 10.1001/archinte.164.10.1108.

引用本文的文献

1
Barriers and Resources to Optimize Bone Health in Orthopaedic Education: Own the Bone (OTB): Bone Health Education in Residency.骨科教育中优化骨骼健康的障碍与资源:掌控骨骼(OTB):住院医师培训中的骨骼健康教育
JB JS Open Access. 2021 Oct 8;6(4). doi: 10.2106/JBJS.OA.21.00026. eCollection 2021 Oct-Dec.
2
The Effect of Postoperative Use of Teriparatide Reducing Screw Loosening in Osteoporotic Patients.特立帕肽术后使用对减少骨质疏松症患者螺钉松动的影响。
J Korean Neurosurg Soc. 2018 Jul;61(4):494-502. doi: 10.3340/jkns.2017.0216. Epub 2018 May 4.
3
Diabetic serum from older women increases adipogenic differentiation in mesenchymal stem cells.
老年女性的糖尿病血清会增加间充质干细胞的成脂分化。
Endocr Res. 2018 Aug;43(3):155-165. doi: 10.1080/07435800.2018.1441868. Epub 2018 Mar 9.
4
Correlation between Reproductive Hormonal Level and Osteoporosis among Women in Mongolia.蒙古国女性生殖激素水平与骨质疏松症之间的相关性
Cent Asian J Glob Health. 2016 May 6;4(2):239. doi: 10.5195/cajgh.2015.239. eCollection 2015.
5
Efficacy of Intraperitoneal Administration of PEGylated NELL-1 for Bone Formation.腹腔注射聚乙二醇化NELL-1促进骨形成的疗效
Biores Open Access. 2016 Jun 1;5(1):159-70. doi: 10.1089/biores.2016.0018. eCollection 2016.
6
Bone mineral density and diet of teachers of College of Home Economics at Lahore.拉合尔家政学院教师的骨矿物质密度与饮食
Pak J Med Sci. 2015 Jul-Aug;31(4):970-4. doi: 10.12669/pjms.314.8433.
7
Pharmacokinetics and osteogenic potential of PEGylated NELL-1 in vivo after systemic administration.聚乙二醇化NELL-1全身给药后的体内药代动力学及成骨潜能
Biomaterials. 2015 Jul;57:73-83. doi: 10.1016/j.biomaterials.2015.03.063. Epub 2015 Apr 24.
8
Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes.2 型糖尿病老年男性骨质疏松症的患病率及其相关因素。
Int J Endocrinol. 2013;2013:285729. doi: 10.1155/2013/285729. Epub 2013 Jan 17.
9
Osteoporosis and type 2 diabetes mellitus: what do we know, and what we can do?骨质疏松症与2型糖尿病:我们了解什么,又能做些什么?
Patient Prefer Adherence. 2012;6:435-48. doi: 10.2147/PPA.S32745. Epub 2012 Jun 11.
10
Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data.绝经后骨折高风险患者骨折的临床危险因素:一项使用电子病历数据的回顾性队列研究。
J Bone Miner Metab. 2011 Mar;29(2):193-200. doi: 10.1007/s00774-010-0207-y. Epub 2010 Aug 6.